Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07564297 · ClinicalTrials.gov registry record

North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia

A clinical trial, sponsored by Mayo Clinic.

Not yet
Registry status
80
Enrollment target

NCT07564297: Clinical Trial study, sponsored by Mayo Clinic.

NCT07564297 is a clinical trial that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07564297 has not yet begun recruiting, sponsored by Mayo Clinic.

NOT YET RECRUITING
Registry status
80 participants
Enrollment target

Study Summary

The purpose of this research is to determine if babies who undergo a Fetoscopic Endoluminal Tracheal Occlusion (FETO) procedure survive more often and have less long-term complications than babies who have similarly severe Congenital Diaphragmatic Hernia (CDH) that have not had the FETO procedure performed during pregnancy

Interventions

  • OTHER Standard of Care
  • DEVICE Fetoscopic Endoluminal Tracheal Occlusion

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2026-06-01
Est. Completion 2038-05-31

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT07564297

The ClinicalTrials.gov registry entry for NCT07564297 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.

NCT07564297 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07564297 about?

NCT07564297 is a clinical study titled "North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia". The purpose of this research is to determine if babies who undergo a Fetoscopic Endoluminal Tracheal Occlusion (FETO) procedure survive more often and have less long-term complications than babies who have similarly severe Congenital Diaphragmatic Hernia (CDH) that have not had the FETO procedure pe...

What is the current status of trial NCT07564297?

This trial is currently not yet recruiting. The enrollment target is 80 participants. The study started on 2026-06-01. Estimated completion is 2038-05-31.

What interventions are being tested in trial NCT07564297?

The interventions under investigation include: Standard of Care (OTHER), Fetoscopic Endoluminal Tracheal Occlusion (DEVICE).

Who is sponsoring clinical trial NCT07564297?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.